Tomohiro Yamasaki

Years Active: 2018-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Tyrone Dowdy, Helena Muley Vilamu, Adrian Lita, Aiguo Li, Tomohiro Yamasaki, Lumin Zhang, Raj Chari, Hua Song, Meili Zhang, Wei Zhang, Nicole Briceno, Dionne Davis, Mark R Gilbert, Mioara Larion
Targeting the sphingolipid rheostat in IDH1 mut glioma alters cholesterol homeostasis and triggers apoptosis via membrane degradation. bioRxiv : the preprint server for biology (2024)
Makoto Horikawa, Shinichiro Koizumi, Tomoya Oishi, Taisuke Yamamoto, Masashi Ikeno, Masahiko Ito, Tomohiro Yamasaki, Shinji Amano, Tetsuro Sameshima, Yasuyuki Mitani, Yoshihiro Otani, Yuanqing Yan, Tetsuro Suzuki, Hiroki Namba, Kazuhiko Kurozumi
Potent bystander effect and tumor tropism in suicide gene therapy using stem cells from human exfoliated deciduous teeth. Cancer gene therapy (2022)
Adrian Lita, Artem Pliss, Andrey Kuzmin, Tomohiro Yamasaki, Lumin Zhang, Tyrone Dowdy, Christina Burks, Natalia de Val, Orieta Celiku, Victor Ruiz-Rodado, Elena-Raluca Nicoli, Michael Kruhlak, Thorkell Andresson, Sudipto Das, Chunzhang Yang, Rebecca Schmitt, Christel Herold-Mende, Mark R Gilbert, Paras N Prasad, Mioara Larion
IDH1 mutations induce organelle defects via dysregulated phospholipids. Nature communications 12 (1) (2021)
Tomohiro Yamasaki, Naoto Sakai, Kazuya Shinmura, Hiroshi Kawaji, Shinichiro Koizumi, Tetsuro Samashima, Hiroki Namba
Anaplastic changes of diffuse leptomeningeal glioneuronal tumor with polar spongioblastoma pattern. Brain tumor pathology 35 (4) (2018)

Tomohiro Yamasaki.css-eqlu8i{font-size:small;padding-left:4px;}